Welcome to the ACR Convergence 2021 Late-Breaking Abstract Submission Site!
The American College of Rheumatology (ACR) and the Association of Rheumatology Professionals (ARP) invite you to submit an abstract and take advantage of the opportunity to have your work peer reviewed by experts in the field. If accepted, your abstract will be published in an online supplement of the Arthritis & Rheumatology journal and displayed in the distinguished international venue of ACR Convergence 2021.
We have an action-packed event planned, kicking off on November 1 with early access to the virtual meeting platform, followed by advance programming on November 3–5 (including the all-new Global Rheumatology Summit, Basic and Clinical Research Conference, and Radiology Bootcamp), ACR Convergence scientific programming and special events on November 5–9, and the ACR Review Course on November 10.
Due to hardships from the COVID-19 pandemic, late-breaking abstract fees have been reduced from $130 to $95. It is our hope this will increase opportunity for submitters during this difficult time. The deadline for late-breaking submission is Tuesday, September 28.
Late-Breaking Abstract Eligibility
Persons Eligible to Submit
- Members and non-members of the ACR and ARP are eligible to submit an abstract.
Abstracts Eligible for Late-Breaking Submission
- Truly late-breaking, high-impact scientific research for which results were not available at the time of the Tuesday, June 1 abstract submission deadline.
- Late-breaking abstracts describing clinical trials or original and groundbreaking basic science may be submitted.
Abstracts Not Eligible for Submission
- Abstracts submitted in the general abstract submission but not accepted should not be submitted to the late-breaking category.
- An abstract is ineligible for consideration if it reports work that has been accepted for publication as a manuscript (e.g., full-length article, brief report, case report, concise communication or letter to the editor, etc.) prior to the late-breaking submission deadline of noon ET on Tuesday, September 28.
- An abstract is ineligible for consideration if preliminary data were available at the time of the Tuesday, June 1 general abstract submission deadline.
- Multiple abstracts may not be submitted for one study unless substantially different research questions are being addressed in each abstract.
- Case reports are not considered appropriate and will not be reviewed.
Browser Requirements: Google Chrome is the recommended browser for accessing your speaker/moderator resource center. You may experience issues when using Internet Explorer or Microsoft Edge. The ACR uses a single-sign on process that allows speakers and moderators to log into their portal via their rheumatology.org account.